mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |